3SAUDEK CD, HERMAN W H, SACKSDB, et al. Anew look at screening and diagnosing diabetes mellitus [J]. J Clin Endocrinol Metab, 2008, 93: 2447-2453.
4HERMAN W H, FAJANS S S. Hemoglobin Alc for thediagnosis of diabetes: practical considerations[J]. Pol Arch Med Wewn, 2010, 120:37- 40.
5BAO Y, MA X, I.I H, et al. Glycated haemoglobin Alc for diagnosing diabetes in Chinese population: cross sectional epidemiologieal survey [J]. BMJ, 2010, 340: c2219.
6Diabetes Prevention Program Research Group. The prevalence of retinopathy in impaired glucose tolerance and recent-onset diabetes in the Diabetes Prevention Program [J]. Diahet Med, 2007, 24:137- 144.
7HERMAN W H. Diabetes epidemiology: guiding clinical and public health practice: the Kelly West Award I.ecture, 2006[J]. Diabetes Care, 2007, 30: 1912 -1919.
8SUMNER C J, SHETH S, GRIFFIN J W, et al. Tbe spectrum ofneuropathy in diabetes and impaired glucnsc tolerance [J]. Neurology, 2003, 60: 108-111.
9QIAO Q, TUOMII.EHTO J, BAI.KAU B, et al. Are insulin resistance, impaired fasting glucose and impaired glucose tolerance all equally strongly related to age [J]. Diabet Med, 2005, 22:1476- 1481.
10MANI.EY S. Haemoglobin Alc a marker for complications of type 2 diabetes: the experience from the I.JK Prospective Diabetes Study (UKPDS) [J]. Clin Chem l.ab Med, 2003, 41: 1182-1190.
